CompletedNot Applicable

Tranexamic Acid in Pregnant Women Undergoing Cesarean Section.

Egypt180 participantsStarted 2019-01-01

Plain-language summary

Purpose to evaluate the effects of topical tranexamic acid (TA) on reducing post-partum hemorrhage in pregnant women with hemorrhagic cesarean section

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients who were admitted for an elective or non-emergency CS during labor and exposed to intraoperative bleeding about 800 ml Exclusion Criteria: * placenta praevia and placental abruption * Women with a medical disorder, * placenta accrete, * allergy to TA, and * intraoperative bleeding thanks to causes aside from uterine atony * Patients over 40 or who have * pre-existing coagulation disorders, * with a severe medical disorder * allergy to tranexamic acid * refuse to consent

What they're measuring

number of patients need of additional pharmacological uterotonic

Timeframe: 24 hours post operative

Trial details

NCT IDNCT03778242

SponsorAswan University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-03-30

View on ClinicalTrials.gov More Cesarean Section Complications trials